Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2687-2691

  Goren, Moran G ^a   Navon Venezia, Shiri ^a   Chmelnitsky, Inna ^a   Carmeli, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN KPC2; TIGECYCLINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATE; CLONE; ESCHERICHIA COLI; ISRAEL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; ISRAEL; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PLASMIDS; TIME FACTORS;

EID: 77952601797     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01359-09     Document Type: Article

References (34)

1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.
2. Bratu, S., S. Brooks, S. Burney, S. Kochar, J. Gupta, D. Landman, and J. Quale. 2007. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975.
3. Cai, J. C., H. W. Zhou, R. Zhang, and G. X. Chen. 2008. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob. Agents Chemother. 52:2014-2018.
4. Cendejas, E., R. Gómez-Gil, P. Gómez-Sánchez, and J. Mingorance. 14 July 2009, posting date. Detection and characterization of Enterobacteriaceae producing metallo-beta-lactamases in a tertiary-care hospital in Spain. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2009.02888.
5. Chmelnitsky, I., O. Hermesh, S. Navon-Venezia, J. Strahilevitz, and Y. Carmeli. 2009. Detection of aac(6′)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J. Antimicrob. Chemother. 64:718-722.
6. KPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob. Agents Chemother. 52:2962-2965.
7. Chmelnitsky, I., Y. Carmeli, A. Leavitt, M. J. Schwaber, and S. Navon-Venezia. 2005. CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49:4745-4750.
8. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - seventh edition. M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. M100-S20. Vol 30, no 1. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Dice, L. R. 1945. Measures of the amount of ecologic association between species. Ecology 26:297-302.
11. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
12. Jaureguy, F., L. Landraud, V. Passet, L. Diancourt, E. Frapy, G. Guigon, E. Carbonnelle, O. Lortholary, O. Clermont, E. Denamur, B. Picard, X. Nassif, and S. Brisse. 2008. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BCM Genomics 9:560. doi:10.1186/1471-2164-9-560.
13. Leavitt, A., S. Navon-Venezia, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli. 2007. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother. 51:3026-3029.
14. Leavitt, A., I. Chmelnitsky, I. Ofek, Y. Carmeli, and S. Navon-Venezia. 2010. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. J. Antimicrob. Chemother. 65:243-248.
15. Liu, Y. F., J. J. Yan, W. C. Ko, S. H. Tsai, and J. J. Wu. 2008. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J. Antimicrob. Chemother. 61:1020-1023.
16. Marchaim, D., S. Navon-Venezia, M. J. Schwaber, and Y. Carmeli. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418.
17. Mathew, M., M. Harris, M. J. Marshall, and G. W. Rose. 1975. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J. Gen. Microbiol. 88:169-178.
18. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395-397.
19. KPC gene. Antimicrob. Agents Chemother. 52:1257-1263.
20. Naseer, U., B. Haldorsen, S. Tofteland, K. Hegstad, F. Scheutz, G. S. Simonsen, A. Sundsfjord, and the Norwegian ESBL Study Group. 2009 Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 117:526-536.
21. Navon-Venezia, S., A. Leavitt, M. J. Schwaber, J. K. Rasheed, A. Srinivasan, J. B. Patel, Y. Carmeli, and the Israeli KPC Kpn Study Group. 2009. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53:818-820.
22. Navon-Venezia, S., I. Chmelnitsky, A. Leavitt, M. J. Schwaber, D. Schwartz, and Y. Carmeli. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.
23. Noller, A. C., M. C. McEllistrem, O. C. Stine, J. G. Morris, Jr., D. J. Boxrud, B. Dixon, and L. H. Harrison. 2003. Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J. Clin. Microbiol. 41:675-679.
24. Odeh, R., S. Kelkar, A. M. Hujer, R. A. Bonomo, P. C. Schreckenberger, and J. P. Quinn. 2002. Broad resistance due to plasmid-mediated AmpC β-lactamases in clinical isolates of Escherichia coli. Clin. Infect. Dis. 35:140-145.
25. Oteo, J., A. Delgado-Iribarren, D. Vega, V. Bautista, M. C. Rodríguez, M. Velasco, J. M. Saavedra, M. Pérez-Vázquez, S. García-Cobos, L. Martínez-Martínez, and J. Campos. 2008. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents. 32:534-537.
26. IMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin. Infect. Dis. 41:1549-1556.
27. Petrella, S., N. Ziental-Gelus, C. Mayer, M. Renard, V. Jarlier, and W. Sougakoff. 2008. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob. Agents Chemother. 52:3725-3736.
28. Poirel, L., C. Heritier, and C. Spicq. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833.
29. Poirel, L., S. Marque, C. Heritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208.
30. Schwaber, M. J., and Y. Carmeli. 2008. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 300:2911-2913.
31. Schwaber, M. J., S. Klarfeld-Lidji, S. Navon-Venezia, D. Schwartz, A. Leavitt, and Y. Carmeli. 2008. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob. Agents Chemother. 52:1028-1033.
32. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
33. Urban, C., P. A. Bradford, M. Tuckman, S. Segal-Maurer, W. Wehbeh, L. Grenner, R. Colon-Urban, N. Mariano, and J. J. Rahal. 2008. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities. Clin. Infect. Dis. 46:e127-e130.
34. Vitti, D., E. Protonotariou, and D. Sofianou. 2009. Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community. Int. J. Antimicrob. Agents 34:187-188.